黄李,童南伟

• 1:四川大学华西医院内分泌代谢科

摘要(Abstract)：

<正>2013年美国内分泌医师协会(AACE)与美国内分泌协会(ACE,注:ACE是AACE下属负责教育的分支机构,实际是一个协会)在AACE年会上共同发布了新版糖尿病综合管理流程图,该图包括糖尿病前期管理、血糖控制以及以患者为中心的超重和肥胖患者管理、心血管危险因素的纠正以及加用/强化胰岛素治疗的流程图,其中有关血

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 黄李,童南伟

参考文献(References)：

• [1]Abrahamson MJ,Grunberger George,Barzilay JI,et al.American Association of Clinical Endocrinology(AACE),AACE Comprehensive Diabetes Management Algorithm[J].Endocr Pract,2013,19(2):327-336.
• [2]Inzucchi SE,Bergenstal RM,Buse JB,et al.American Diabetes Association(ADA)European Association for the Study of Diabetes(EASD).Management of hyperglycemia in type 2diabetes:a patient-centered approach:position statement of the American Diabetes Association(ADA)and the European Association for the Study of Diabetes(EASD)[J].Diabetes Care,2012,35(6):1364-1379.
• [3]中华医学会内分泌学分会.中国成人2型糖尿病HbA1c控制目标的专家共识[J].中华内分泌代谢杂志,2011,27(5):371-374.
• [4]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国医学前沿杂志(电子版),2011,3(6):54-104.
• [5]Schernthaner G,Grimaldi A,DiMario U,et al.GUIDE study:double-blind comparison of once-daily gliclazide MR and glimepiride in type2 diabetic patients[J].Eur J Clin Invest,2004,34(8):535-542.
• [6]UK Prospective Diabetes Study(UKPDS)Group.Intensive blood-glucose control with sulphonylureas or insulin compared with Conventional treatment and risk of complications in patients with type2 diabetes(UKPDS33)[J].Lancet,1998,352(9131):837-853.
• [7]ADVANCE Collaborative Group.Intensive blood glucose control and vascular outcomes in patients with type 2diabetes[J].N Engl J Med,2008,358(24):2560-2572.
• [8]Jameson K,Dixon T,Mann R,et al.Hypoglycaemia in type 2diabetes[J].Diabetic Medicine,2008,25(3):245-254.
• [9]Pulizzi N.The place of sulfonylureas in the therapy for type 2diabetes mellitus[J].Metabolism,2006,55(5Suppl1):21-22.
• [10]González-Ortiz M,Guerrero-Romero JF,Violante-Ortiz R,et al.Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patien ts with uncontrolled type 2diabetes mellitus[J].Journal of Diabetes and Its Complications,2009,23(6):376-379
• [11]van Dieren S,Czernichow S,Chalmers J,et al.Weight changes and their predictors amongst 11140 patients with type 2diabetes in the ADVANCE trail[J].Diabetes Obesity Metab,2012,14(5):464-469.
• [12]Schernthaner G,Grimaldi A,DiMario U,et al.GUIDE study:double-blind comparison of once-daily gliclazide MR and glimepiride in type2 diabetic patients[J].Eur J Clin Invest,2004,34(8):535-542.
• [13]Diamicron MR Study Group.Diamicron1 MR once daily is effective and well tolerated in type 2 diabetes A double-blind,randomized,multinational study[J].Diabetes Complications,2000,14(4):185-191.
• [14]Alvarsson M.Effects of insulin vs.glibenclamide in recently diagnosed patients with type 2 diabetes:a 4-year follow-up[J].Diabetes,Obesity and Metabolism,2008,10(5):421-429.
• [15]Hydrie MZI.Basit A.Glimepiride study on type-2 diabetic subjects[J].Pak J Med Sci,2006,22(2):132-135.
• [16]Hoechst-Roussel Pharmaceuticals,Inc Amaryl(glimepiride)prescribing information.Somerville NJ,Hoechst-Roussel Pharmaceuticals,Inc 1995.